The effects of orchidectomy and supraphysiological testosterone administration on trabecular bone structure and gene expression in rats

References

• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465–75
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726–33
   PubMed Web of Science ®Google Scholar
• Chin KY, Ima-Nirwana S. Sex steroids and bone health status in men. Int J Endocrinol 2012;2012:208719
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833–76
   PubMed Web of Science ®Google Scholar
• Filipović B, Šošić-Jurjević B, Ajdžanović V, et al. The effects of sex steroids on thyroid C cells and trabecular bone structure in the rat model of male osteoporosis. J Anat 2013;222:313–20
   PubMed Web of Science ®Google Scholar
• Libouban H, Moreau MF, Legrand E, et al. Comparison of histomorphometric descriptors of bone architecture with dual-energy X-ray absorptiometry for assessing bone loss in the orchidectomized rat. Osteoporos Int 2002;13:422–8
   PubMedGoogle Scholar
• Lelovas PP, Xanthos TT, Thoma SE, et al. The laboratory rat as an animal model for osteoporosis research. Comp Med 2008;58:424–30
   PubMed Web of Science ®Google Scholar
• Proell V, Xu H, Schuler C, et al. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats. Bone 2009;45:677–81
   PubMedGoogle Scholar
• Gaumet-Meunier N, Coxam V, Robins S, et al. Gonadal steroids and bone metabolism in young castrated male rats. Calcif Tissue Int 2000;66:470–5
   PubMedGoogle Scholar
• Shuid AN, Abu Bakar MF, Abdul Shukor TA, et al. The anti-osteoporotic effect of Eurycoma Longifolia in aged orchidectomised rat model. Aging Male 2011;14:150–4
   PubMed Web of Science ®Google Scholar
• Shuid A, El-arabi E, Effendy N, et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. BMC Complement Altern Med 2012;12:152
   PubMedGoogle Scholar
• Balkan W, Burnstein KL, Schiller PC, et al. Androgen-induced mineralization by MC3T3-E1 osteoblastic cells reveals a critical window of hormone responsiveness. Biochem Biophys Res Commun 2005;328:783–9
   PubMedGoogle Scholar
• Liu X-H, Kirschenbaum A, Yao S, Levine AC. Androgens promote preosteoblast differentiation via activation of the canonical Wnt signaling pathway. Ann N Y Acad Sci 2007;1116:423–31
   PubMed Web of Science ®Google Scholar
• Huber DM, Bendixen AC, Pathrose P, et al. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 2001;142:3800–8
   PubMed Web of Science ®Google Scholar
• Tracz MJ, Sideras K, Boloña ER, et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 2006;91:2011–16
   PubMed Web of Science ®Google Scholar
• Yarrow JF, Conover CF, Purandare AV, et al. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. Am J Physiol Endocrinol Metab 2008;295:E1213–22
   PubMed Web of Science ®Google Scholar
• Borst SE, Conover CF, Carter CS, et al. Anabolic effects of testosterone are preserved during inhibition of 5α-reductase. Am J Physiol Endocrinol Metab 2007;293:E507–14
   PubMed Web of Science ®Google Scholar
• Tajul Ariff AS, Soelaiman IN, Pramanik J, Shuid AN. Effects of Eurycoma longifolia on testosterone level and bone structure in an aged orchidectomised rat model. Evid Based Complement Alternat Med 2012;2012:818072
   PubMed Web of Science ®Google Scholar
• Tyagi A, Rajalakshmi B, Kumar VM. Effects of long-term treatment with testosterone enanthate in rhesus monkeys: I. Pharmacokinetics of testosterone, testicular volume and liver metabolism of testosterone. Int J Androl 1999;22:139–47
   PubMedGoogle Scholar
• Ramli R, Khamis MF, Shuid AN. Bone Micro-CT assessments in an orchidectomised rat model supplemented with Eurycoma longifolia. Evid Based Complement Alternat Med 2012;2012:501858
   PubMed Web of Science ®Google Scholar
• Soung DY, Devareddy L, Khalil DA, et al. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif Tissue Int 2006;78:385–91
   PubMed Web of Science ®Google Scholar
• Falahati-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553–60
   PubMed Web of Science ®Google Scholar
• Wang J, Stern PH. Sex-specific effects of estrogen and androgen on gene expression in human monocyte-derived osteoclasts. J Cell Biochem 2011;112:3714–21
   PubMedGoogle Scholar
• Franklin M, Bu SY, Lerner MR, et al. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone 2006;39:1331–42
   PubMed Web of Science ®Google Scholar
• Pepene C, Crişan N, Coman I. Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. Clin Invest Med 2011;34:E232–7
   Google Scholar
• Frederiksen L, Glintborg D, Hojlund K, et al. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. Horm Metab Res 2013;45:308–13
   PubMed Web of Science ®Google Scholar
• Steffens JP, Herrera BS, Coimbra LS, et al. Testosterone regulates bone response to inflammation. Horm Metab Res 2014;46:193–200
   PubMedGoogle Scholar
• Hofbauer LC, Hicok KC, Chen D, Khosla S. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. Eur J Endocrinol 2002;147:269–73
   PubMedGoogle Scholar
• Borst SE, Lee JH, Conover CF. Inhibition of 5α-reductase blocks prostate effects of testosterone without blocking anabolic effects. Am J Physiol Endocrinol Metab 2005;288:E222–7
   PubMed Web of Science ®Google Scholar